Position in ABBV
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$2,883,794
+$835,474 QoQ
Shares Held
11,460
+21.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#1,678
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2021CallValue
$67,584
CallShares
600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cooper Financial Group holds $19,451,562 across 11 Drug Manufacturers - General names. ABBV ranks #3 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,274 | $6,325,794 | |
| 2 | AMGN |
Amgen Inc
|
8,265 | $2,992,921 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
11,460 | $2,883,794 | |
| 4 | JNJ |
Johnson & Johnson
|
10,851 | $2,755,828 | |
| 5 | AZN |
Astrazeneca PLC
|
6,342 | $1,202,570 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,089 | $1,039,436 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,387 | $713,738 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,403 | $556,275 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,883,794 | 11,460 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $2,048,320 | 9,418 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $2,099,594 | 9,189 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $2,018,797 | 8,719 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $1,575,728 | 8,489 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $2,107,352 | 10,058 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,819,825 | 10,241 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,890,476 | 9,573 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,120,844 | 12,365 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $2,372,398 | 13,028 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $1,773,011 | 11,441 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $1,607,164 | 10,782 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $1,496,580 | 11,108 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $1,656,810 | 10,396 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,563,415 | 9,674 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $971,948 | 7,242 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $1,003,351 | 6,551 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $877,663 | 5,414 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $773,269 | 5,711 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,024,009 | 9,493 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $67,584 | 600 | Call | Sole | 2021-07-12 | |
| 2021-06-30 | $942,909 | 8,371 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $722,152 | 6,673 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,203,401 | 11,231 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $559,086 | 6,383 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $544,309 | 5,544 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $395,578 | 5,192 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||